Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. ÌýYou can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
WELCOME BACK
or
Prostate Cancer, Version 3.2024.
À¶Ý®ÊÓƵ
Prostate Cancer, Version 3.2024. Journal of the National Comprehensive Cancer Network : JNCCN Schaeffer, E. M., Srinivas, S., Adra, N., An, Y., Bitting, R., Chapin, B., Cheng, H. H., D'Amico, A. V., Desai, N., Dorff, T., Eastham, J. A., Farrington, T. A., Gao, X., Gupta, S., Guzzo, T., Ippolito, J. E., Karnes, R. J., Kuettel, M. R., Lang, J. M., Lotan, T., McKay, R. R., Morgan, T., Pow-Sang, J. M., Reiter, R., Roach, M., Robin, T., Rosenfeld, S., Shabsigh, A., Spratt, D., Szmulewitz, R., Teply, B. A., Tward, J., Valicenti, R., Wong, J. K., Snedeker, J., Freedman-Cass, D. A. 2024; 22 (3): 140-150Abstract
The NCCN Guidelines for Prostate Cancer include recommendations for staging and risk assessment after a prostate cancer diagnosis and for the care of patients with localized, regional, recurrent, and metastatic disease. These NCCN Guidelines Insights summarize the panel's discussions for the 2024 update to the guidelines with regard to initial risk stratification, initial management of very-low-risk disease, and the treatment of nonmetastatic recurrence.
View details for
View details for